PHAXIAM Therapeutics ADR
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PHXM and buy or sell other stocks, ETFs, and their options commission-free!About PHXM
PHAXIAM Therapeutics SA operates as a biopharmaceutical company. It engages in the development of treatments for resistant bacterial infections.
CEOThibaut du Fayet, MBA
CEOThibaut du Fayet, MBA
Employees—
Employees—
HeadquartersLyon, Auvergne-Rhone-Alpes
HeadquartersLyon, Auvergne-Rhone-Alpes
Founded2004
Founded2004
Employees—
Employees—
PHXM Key Statistics
Market cap29.46M
Market cap29.46M
Price-Earnings ratio-0.83
Price-Earnings ratio-0.83
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.10
52 Week high$3.10
52 Week low$3.10
52 Week low$3.10
Stock Snapshot
The current PHAXIAM Therapeutics ADR(PHXM) stock price is $4.85, with a market capitalization of 29.46M. The stock trades at a price-to-earnings (P/E) ratio of -0.83.
PHAXIAM Therapeutics ADR(PHXM) stock opened on 2025-12-11 at —. The price climbed to — and dipped to —.
PHAXIAM Therapeutics ADR(PHXM) shares are trading with a volume of 0.
In the last year, PHAXIAM Therapeutics ADR(PHXM) shares hit a 52-week high of $3.10 and a 52-week low of $3.10.
In the last year, PHAXIAM Therapeutics ADR(PHXM) shares hit a 52-week high of $3.10 and a 52-week low of $3.10.